DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
De Wit R, de Bono J, Sternberg CN. et al.
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.
N Engl J Med 2019;
381: 2506-2518
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.